Namrata D Udeshi Selected Research

Namrata D Udeshi Research Topics

Disease

17	Neoplasms (Cancer) 06/2023 - 01/2014
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 07/2015
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 10/2014
3	Breast Neoplasms (Breast Cancer) 01/2020 - 09/2015
3	Multiple Myeloma 10/2018 - 01/2014
2	Testicular Neoplasms (Testicular Cancer) 06/2023 - 01/2023
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2017
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 11/2019
2	Lymphoma (Lymphomas) 01/2021 - 10/2019
2	Virus Diseases (Viral Diseases) 01/2018 - 08/2013
1	Muscular Atrophy (Muscle Atrophy) 11/2023
1	Muscular Diseases (Myopathy) 11/2023
1	Nemaline Myopathies (Nemaline Myopathy) 11/2023
1	Disease Progression 11/2023
1	Aneuploidy (Aneuploid) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Autistic Disorder (Autism) 01/2021
1	16p11.2 Deletion Syndrome 01/2021
1	Epilepsy (Aura) 01/2021
1	Teratoma (Teratoid Tumor) 01/2021
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2021
1	Adenocarcinoma of Lung 01/2020
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	Endometrial Neoplasms (Endometrial Cancer) 01/2017
1	Synucleinopathies 01/2017
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2014
1	Leukemia 07/2013
1	Infections 03/2011
1	Polyploidy 01/2010

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2010
7	UbiquitinIBA 11/2023 - 10/2014
5	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2023 - 10/2014
5	Ligases (Synthetase)IBA 01/2023 - 01/2017
5	Lenalidomide (CC 5013)FDA Link 01/2020 - 01/2014
3	Peptides (Polypeptides)IBA 06/2023 - 09/2015
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2014
3	Thalidomide (Thalomid)FDA Link 11/2019 - 01/2018
2	ProteomeIBA 11/2023 - 01/2018
2	AntigensIBA 06/2023 - 01/2023
2	alpha-SynucleinIBA 01/2022 - 01/2017
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 01/2020
2	pomalidomideIBA 10/2018 - 01/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2023
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2023
1	hypusineIBA 01/2023
1	MTOR InhibitorsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	InterferonsIBA 01/2022
1	Adenylosuccinate lyase deficiencyIBA 01/2021
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	AndrogensIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	SurvivinIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Protein SIBA 01/2021
1	ChromatinIBA 01/2021
1	GlucocorticoidsIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	SteroidsIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	venetoclaxIBA 10/2019
1	Immunomodulating AgentsIBA 01/2018
1	LithiumIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 09/2015
1	Histones (Histone)IBA 10/2014
1	Carrier Proteins (Binding Protein)IBA 10/2014
1	Insulin (Novolin)FDA Link 01/2014
1	Bortezomib (Velcade)FDA Link 07/2013
1	Capsid Proteins (Capsid Protein)IBA 03/2011
1	EnzymesIBA 01/2010
1	O-GlcNAc transferaseIBA 01/2010

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2021
1	Immunotherapy 06/2023